Modern methods for predicting cardiovascular disease in the long term among women who have undergone preeclampsia
Abstract
The review presents the results of an analysis of data from domestic and foreign literature about preeclampsia, which is one of the main causes of perinatal morbidity and mortality. Women with preeclampsia subsequently have an increased risk of developing cardiovascular complications. The main clinical and pathogenetic mechanisms affecting the occurrence of preeclampsia are considered.
The main attention in the work is focused on the characteristic features of the clinical course, bio-chemical predictors of preeclampsia sflt-1/PIGF, PAPP-A, features of the echocardiographic manifestation of prеeclampsia and its association with cardiovascular diseases in the distant period.
About the Authors
M. B. Baurzhan
Kazakh Medical University of Continuing Education
Kazakhstan
Kazakhstan
Almaty
K. B. Abzaliev
Kazakh Medical University of Continuing Education
Kazakhstan
Kazakhstan
Kuat Bayandievich Abzaliev - Doctor of Medical Sciences, Professor of the Department of Cardiovascular and X-ray Endovascular Surgery
Almaty
G. S. Svyatova
Research Institute of Cardiology and Internal Medicine
Kazakhstan
Kazakhstan
Almaty
D. D. Mirzakhmetova
Scientific Center for Obstetrics, Gynecology and Perinatology
Kazakhstan
Kazakhstan
Almaty
S. F. Berkinbaev
Kazakh National Medical University named after S. D. Asfendiyarov
Kazakhstan
Kazakhstan
Almaty
G. Zh. Bodykov
Center for Perinatology and Pediatric Cardiac Surgery
Kazakhstan
Kazakhstan
Almaty
S. A. Abzalieva
Kazakh National University named after al-Farabi
Kazakhstan
Kazakhstan
Almaty
B. T. Mukhamadiev
Kazakh National University named after al-Farabi
Kazakhstan
Kazakhstan
Almaty
References
1. Brown, M.A.; Magee, L.A.; Kenny, L.C.; Karumanchi, S.A.; McCarthy, F.P.; Saito, S.; Hall, D.R.; Warren, C.E.; Adoyi, G.; Ishaku, S. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension 2018, 72, 24–43.
2. Grand’Maison S, Pilote L, Schlosser K, Stewart DJ, Okano M, Dayan N. Clinical features and outcomes of acute coronary syndrome in women with previous pregnancy complications.Can J Cardiol. 2017; 33:1683–1692. doi: 10.1016/j.cjca.2017.08.025)
3. Statisticheskij sbornik «Zdorov'e naselenija Respubliki Kazahstan i dejatel'nosti organizacij zdravoohranenija v 2018 godu» MZ RK http://dsm.gov.kz/ru/kategorii/statistika-0
4. «Prognozirovanie i doklinicheskaja diagnostika prejeklampsii u beremennyh s rannej jendotelial'noj disfunkciej» Velikoreckaja O.A. 2017, Moskva
5. van Esch JJA, van Heijst AF, de Haan AFJ, van der Heijden OWH. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Matern Fetal Neonatal Med. 2017;30(23):2789–94. https://doi.org/10.1080/14767058.2016.1263295.
6. Tenney B, Parker F. The placenta in toxemia of pregnancy. Am J Obstet Gynecol. 1940;39:1000–1005.
7. «Gipertenzivnyj sindrom u beremennyh: porazhenie organov-mishenej i faktory riska razvitija prejeklampsii» Aksenova A.S. 2017, Perm'
8. Giannakou K, Evangelou E, Papatheodorou SI. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol. 2018;51:720–730. doi: 10.1002/uog.18959
9. Wei J, Liu CX, Gong TT, Wu QJ, Wu L. Cigarette smoking during pregnancy and preeclampsia risk: a systematic review and metaanalysis of prospective studies. Oncotarget. 2015;6:43667–43678. doi: 10.18632/oncotarget.6190
10. Muresan D, Rotar I, Stamatian F. The usefulness of fetal Doppler evaluation in early versus late onset intrauterine growth restriction. Review of the literature. Medical Ultrasonography.2016;18(1):103-109. //doi.org/10.11152/mu.2013.2066.181.dop
11. McGinnis R, Steinthorsdottir V, Williams NO, et al; FINNPEC Consortium; GOPEC Consortium. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017;49:1255–1260. doi: 10.1038/ng.3895
12. Perspektivy diagnostiki i prognozirovanija prejeklampsii D.m.n., prof. O. V. MAKAROV, k.m.n. E. V. VOLKOVA, asp. L. S. DZhOHADZE ROSSIJSKIJ VESTNIK AKUShERA-GINEKOLOGA 1, 2012 str 37
13. Tangren JS, Powe CE, Ankers E, Ecker J, Bramham K, Hladunewich MA, Karumanchi SA, Thadhani R. Pregnancy outcomes after clinical recovery from AKI. J Am Soc Nephrol. 2017;28:1566–1574. doi: 10.1681/ASN.2016070806
14. Prejeklampsija kak faktor riska vozniknovenija serdechno-sosudistyh zabolevanij u zhenshhin E. V. Volkova, N.K.Runihina, I. N. VinokurovaE. / Vestnik RGMU, 2011, №1, s. 25–30
15. Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women Muthuvel Jayachandran, Vesna D. Garovic, Michelle M. Mielke, Kent R. Bailey, Brian D. Lahr, Virginia M. Miller
16. Preclinical atherosclerosis at the time of preeclamptic pregnancies and up to 10 years postpartum: Systematic review and meta-analysis Natasa M. Milic, MD, PhD,1,2 Jelena Milin-Lazovic, MD,1 Tracey L. Weissgerber, PhD,2 Goran Trajkovic, MD, PhD,1 Wendy M. White, MD,3 and Vesna D. Garovic, MD2,3 September 14, 2017 https://doi.org/10.1371/journal.pone.0183159
17. Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, McEniery CM, Wilkinson IB, Bennett PR, Lees CC. Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction. Hypertension. 2018;72:442–450. doi: 10.1161/HYPERTENSIONAHA.118.11092
18. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873–880. doi: 10.1161/HYPERTENSIONAHA.108.117358
19. Cardiovascular System in Preeclampsia and Beyond. Thilaganathan B1,2, Kalafat E3. Hypertension. 2019 Mar;73(3):522-531. doi: 10.1161/HYPERTENSIONAHA.118.11191
20. Tkacheva O. N., Barabashkina A. V., Razguljaeva N.F., Galjautdinova A.Ju. Izuchenie organoprotektivnyh jeffektov jenalaprila pri lechenii arterial'noj gipertenzii, sohranjajushhejsja posle rodov // Trudnyj pacient. – 2006. – №3. – T. 4. – S. 18–22.
21. McDonald S.D., Han Z., Walsh M.W. et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 2010; 55: 6: 1026—1039.
22. Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, Thilaganathan B, Boyd HA. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017;358:j3078. doi: 10.1136/bmj.j3078
Review
For citations:
Baurzhan M.B., Abzaliev K.B., Svyatova G.S., Mirzakhmetova D.D., Berkinbaev S.F., Bodykov G.Zh., Abzalieva S.A., Mukhamadiev B.T. Modern methods for predicting cardiovascular disease in the long term among women who have undergone preeclampsia. Medicine and ecology. 2021;(4):20-25. (In Russ.)
Views: 191
Email this article 